creatinine

Small moleculeexperimental

Creatinine is a breakdown product of creatine phosphate from muscle and protein metabolism. It is released at a constant rate by the body. — Wikipedia

Clinical trial activity

4 trials · 8 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0

Earliest trial started Jun 1, 2000 (NCT00005766)

Timeline

2000s

  1. Jan 1, 2000

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetSupplementation

    supplementation

Chemistry & pharmacology

Loading structure…

SMILES

CN1CC(=O)NC1=N
Mol. weight
113.12 g/mol
Lipinski Ro5
Pass
Rule of 3
Yes
Chirality
Achiral Molecule
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • creatinine
  • creatinine
  • creatinine
  • creatinine

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT02806089N/AJan 1, 2016CHU Lapeyronie, University of Montpellier
NCT02111148N/AMay 1, 2014Beni Suef University, Cairo University
NCT02280070Phase 2Sep 1, 2013Clinical Research Support Center Kyush, Kurume University, Saiseikai Fukuoka General Hospital
NCT00005766Phase 2Jun 1, 2000National Center for Research Resources (NCRR)
Showing 4 of 4 trials
Page 1 / 1

Organizations

Research & Development (8)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Beni Suef UniversityAcademic/Hospital1112014
Cairo UniversityAcademic/Hospital1012014
CHU LapeyronieAcademic/Hospital1012016
Clinical Research Support Center KyushAcademic/Hospital1112013
Kurume UniversityAcademic/Hospital1012013
National Center for Research Resources (NCRR)Government1112000
Saiseikai Fukuoka General HospitalAcademic/Hospital1012013
University of MontpellierAcademic/Hospital1112016
8 organizations
Page 1 / 1